Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: Comparison of disk diffusion, etest, and time-kill methods

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 2, 2009, Pages 788-790

  Kiraz, Nuri ^a   Daǧ, Ilknur ^a   Yamac, Mustafa ^a   Kiremitci, Abdurrahman ^a   Kaşifoǧlu, Nilgun ^a   Akgun, Yurdanur ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CASPOFUNGIN;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA GLABRATA; CONTROLLED STUDY; DISK DIFFUSION; DRUG POTENTIATION; EPSILOMETER TEST; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; DRUG COMBINATIONS; DRUG SYNERGISM; ECHINOCANDINS; ENDPOINT DETERMINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

EID: 59749100592     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01131-08     Document Type: Article

References (10)

1. Alexander, B., T. C. Byrne, K. L. Smith, K. E. Hanson, K. J. Anstrom, J. R. Perfect, and L. B. Reler. 2007. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J. Clin. Microbiol. 45:698-706.
2. Barchiesi, F., E. Spreghini, A. W. Fothergill, D. Arzeni, G. Greganti, D. Giannini, M. G. Rinaldi, and G. Scalise. 2005. Caspofungin in combination with amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:2546-2549.
3. Barchiesi, F., E. Spreghini, S. Tomassetti, D. Giannini, and G. Scalise. 2007. Caspofungin in combination with amphotericin B against Candida parapsilosis. Antimicrob. Agents Chemother. 51:941-945.
4. Clinical Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeast, 3rd ed. Approved standard M27-A3. Clinical Laboratory Standards Institute, Wayne, PA.
5. Lewis, R. E., D. J. Diekema, S. A. Messer, M. A. Pfaller, and M. E. Klepser. 2002. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J. Antimicrob. Chemother. 49:345-351.
6. Lozano-Chiu, M., P. W. Nelson, V. L. Paetznick, and J. H. Rex. 1999. Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991. J. Clin. Microbiol. 37:1625-1627.
7. Mariné, M., C. Serena, F. J. Pastor, and J. Guarro. 2006. Combined antifungal therapy in a murine infection by Candida glabrata. J. Antimicrob. Chemother. 58:1295-1298.
8. National Committee for Clinical Laboratory Standards. 2002. Method for antifungal disk diffusion susceptibility testing in yeasts. Approved guideline M-44-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
9. Patterson, T. F. 2005. Advances and challenges in management of invasive mycoses. Lancet 366:1013-1025.
10. White, R. L., D. S. Burgess, M. Manduru, and J. A. Bosso. 1996. Comparison of three different in vitro methods of detecting synergy: time-kill, checker-board, and E test. Antimicrob. Agents Chemother. 40:1914-1918.